Bicycle Therapeutics
The Senior Director, Statistical Programming will provide strategic and technical leadership for Bicycle Therapeutics' statistical programming function, overseeing high‑quality data delivery, CDISC compliance, and regulatory submissions across the clinical portfolio. The role includes operational excellence, vendor governance, and mentoring a team of programmers while partnering with Biostatistics and Clinical Development.
Headquarters
Great Abington, England, United Kingdom
Company Size
201-500 employees
Founded
2009
Bicycle Therapeutics is a clinical-stage biopharmaceutical company that pioneers a proprietary "Bicycle" bicyclic peptide platform to create precision-guided therapeutics. Their modular, constrained peptides are engineered to bind targets with high affinity and can be formatted as multispecific agents or linked to payloads (e.g., cytotoxins or immune modulators) to enable targeted delivery, with a strong focus on oncology and other serious diseases. The company emphasizes rapid tissue penetration, scalable chemistry and strategic collaborations to advance a pipeline of targeted therapies toward clinical development.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Bicycle Therapeutics.
8% above the average for this role
Director, Statistical Programming
Seaport Therapeutics
Manager, Statistical Programming
Rhythm Pharmaceuticals
DGM, Statistical Programming
lifelancer
Associate Director, Statistical Programming
Servier
Manager 1, Statistical Programming
Sun Pharmaceutical Industries Limited
Senior Manager, Statistical Programming
immunomeinc